# Plexium

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/plexium

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.plexium.com
- Total disclosed funding: $165M
- Latest round: Series B (Feb 23, 2022)
- Investors on record: 13

## About

Founded in 2018 and based in California, US, Plexium, Inc. operates as a drug development company intended to build a novel therapeutic treatment for cancer and neurodegenerative diseases.

## Funding rounds

- Series B, Feb 23, 2022, $102M — CRV, Pappas Capital, The Column Group, Lux Capital, DCVC, BVF Partners, RA Capital Management, SB Investment Advisers, NeoTribe Ventures, Pivotal Life Sciences, M Ventures, Surveyor Capital, TCG Crossover Management
- Series A, Jan 19, 2021, $35M — The Column Group, Lux Capital, DCVC, Pivotal Life Sciences
- Series A, Oct 17, 2019, $28M — CRV, The Column Group, DCVC, NeoTribe Ventures, M Ventures
- Seed, Oct 1, 2018 — DCVC
- Seed, Feb 1, 2018 — CRV

## Investors

- CRV (https://capitalatlas.ai/funds/crv) — Seed, Series A, Series B
- DCVC (https://capitalatlas.ai/funds/dcvc) — Seed, Series A, Series B
- The Column Group (https://capitalatlas.ai/funds/the-column-group) — Series A, Series B
- NeoTribe Ventures (https://capitalatlas.ai/funds/neotribe-ventures) — Series A, Series B
- M Ventures (https://capitalatlas.ai/funds/m-ventures) — Series A, Series B
- Lux Capital (https://capitalatlas.ai/funds/lux-capital) — Series A, Series B
- Pivotal Life Sciences (https://capitalatlas.ai/funds/pivotal-life-sciences) — Series A, Series B
- Pappas Capital (https://capitalatlas.ai/funds/pappas-capital) — Series B
- BVF Partners (https://capitalatlas.ai/funds/bvf-partners) — Series B
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series B
- SB Investment Advisers (https://capitalatlas.ai/funds/sb-investment-advisers) — Series B
- Surveyor Capital — Series B
- TCG Crossover Management (https://capitalatlas.ai/funds/tcg-crossover-management) — Series B